Effects of dialysis membranes on beta2-microglobulin production and cellular expression

Kidney International

Volumn 38, Issue 5, 1990, Pages 962-968

  Zaoui, Philippe M ^b   Stone, William J ^b   Hakim, Raymond M ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN;

ARTICLE; CLINICAL ARTICLE; DIALYSIS MEMBRANE; HEMODIALYSIS; HUMAN; PRIORITY JOURNAL;

AGED; BETA 2-MICROGLOBULIN; CELLS, CULTURED; CELLULOSE; COMPARATIVE STUDY; HLA ANTIGENS; HUMAN; LEUKOCYTES, MONONUCLEAR; MEMBRANES, ARTIFICIAL; METHYLMETHACRYLATES; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; RENAL DIALYSIS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025087095     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1990.298     Document Type: Article

References (33)

1. 2-microglobulin in human blood cells. J Immunol 111(4):1147-1154, 1973
2. 2-microglobulin in some plasma membranes and biological fluids. Scand J Immunol 11:341-351, 1980
3. 2-microglobulin: The constant chain of HLA-antigens. Eur J Clin Invest 10:293-300, 1980
4. 2-microglobulin: Its significance in the evaluation of renal function. Kidney Int 32:635-641, 1987
5. 2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis. Proc Natl Acad Sci USA 83:7908-7912, 1986
6. 2-microglobulin: Evidence for a new form of hemodialysis-associated amyloid protein. Kidney Int 33(S24): S30-S31, 1988
7. 2-microglobulin. Biochem Biophys Res Commun 129(3):701-706, 1985
8. ULLIAN ME, HAMMOND WS, ALFREY AC, SCHULTZ A, MOLITORIS BA: Beta-2-microglobulin-associated amyloidosis in chronic hemodialysis patients with carpal tunnel syndrome. Medicine 68:107-115, 1989
9. STONE WJ, HAKIM RM: Beta-2-microglobulin amyloidosis in long-term dialysis patients. Am J Nephrol 9:177-183, 1989
10. 2 microglobulin concentration: Possible relation to membrane biocompatibility. Nephrol Dial Transplant 2:22-25, 1987
11. 2-microglobulin kinetics: In vivo and in vitro studies. Nephrol Dial Transplant 3:284-290, 1988
12. 2-M) removal: Which is the best way to achieve a negative balance? (abstract) EDTA p. 221, 1987
13. JORSTAD S, SMEBY LC, BALSTAD T, WIDEROE T-E: Removal, generation and adsorption of beta-2-microglobulin during hemofiltration with five different membranes. Blood Purif 6:96-105, 1988
14. 2-microglobulin removal during hemodialysis, hemodiafiltration and hemofiltration. Nephrol Dial Transplant 4:653-657, 1989
15. 2-microglobulin in patients with chronic renal failure undergoing hemodialysis, hemodiafiltration and continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 27:245-249, 1987
16. HAKIM RM, FEARON DT, LAZARUS JM: Biocompatibility of dialysis membranes: Effects of chronic complement activation. Kidney Int 26:194-200, 1984
17. HAEFFNER-CAVAILLON N, CAVAILLON JM, CIANCIONI C, BACLE F, DELONS S, KAZATCHKINE MD: In vivo induction of interleukin-1 during hemodialysis. Kidney Int 35:1212-1218, 1989
18. LONNEMAN G, VAN DER MEER JWM, CANNON JG, DINARELLO CA, KOCH KM, GRANOLLERAS C, DESCHODT G, SHALDON S: Induction of tumor necrosis factor during extracorporeal blood purification. N Engl J Med (letter) 317:963-964, 1989
19. 2-microglobulin by stimulated lymphocytes. J Immunol 109(2):407-409, 1972
20. 2-microglobulin by normal and malignant human cell lines and peripheral lymphocytes. Transplant Rev 21:53-84, 1974
21. LE BOUTEILLER PP, MISHAL Z, LEMONNIER FA, KOURILSKY FM: Quantification by flow cytofluorimetry of HLA Class I molecules at the surface of murine cells transformed by cloned HLA genes. J Immunol Meth 61:301-315, 1983
22. KNUDSEN PJ, NG A-K, LIU Z: Beta-2 microglobulin synthesis is increased during activation of human monocytes. Blood Purif 6:178-187, 1988
23. KNUDSEN PJ, LEON J, NG A-K, SHALDON S, FLOEGE J, KOCH KM: Hemodialysis-related induction of beta-2-microglobulin and interleukin-1 synthesis and release by mononuclear phagocytes. Nephron 53:188-193, 1989
24. FEARON DT: Complement, C receptors and immune complex disease. Hospital Practice 23:63-72, 1988
25. ROYER HD, REINBERZ EL: T lymphocytes: Ontogeny, function, and relevance to clinical disorgers. N Engl J Med 317:1136-1142, 1987
26. ÖHLEN C, BEJARANO M-T, GRÖNBERG A, TORSTEINSDOTTIR S, FRANKSSON L, LJUNGGREN H-G, KLEIN E, KLEIN G, KARRE K: Studies of sublines selected for loss of HLA expression from an EBV-transformed lymphoblastoid cell line. J Immunol 142(9):3336-3341, 1989
27. 2-microglobulin expression. Scand J Immunol 30:21-29, 1989
28. SHIMIZU Y, DEMARS R: Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell-mediated lysis is inversely correlated with HLA class I antigen expression. Eur J Immunol 19:447-451, 1989
29. ROLA-PLESZCZYNSKI M, BOLDUC D, FORAND S, PLANTE GE, ST-PIERRE S: Cellular immune function in uremia: Altered cytotoxic and suppressor cell responses to an immunomodulating heptapeptide. Clin Immunol Immunopathol 28:177-184, 1983
30. LOBO PI, SPENCER CE: Use of anti-HLA antibodies to mask major histocompatibility complex gene products on tumor cells can enhance susceptibility of these cells to lysis by natural killer cells. J Clin Invest 83:278-287, 1989
31. BINGEL M, LONNEMANN G, KOCH KM, DINARELLO CA, SHALDON S: Enhancement of in-vitro human interleukin-1 production by sodium acetate. Lancet 1:14-16, 1987
32. 5a induction of human interleukin 1. Synergistic effect with endotoxin or interferron. J Immunol 139:2635-2640, 1987
33. MION CM, CANAUD B, GARRED LJ, STEC F, NGUYEN QV: Sterile and pyrogen-free bicarbonate dialysate: A necessity for hemodialysis today. Adv Nephrol 19:275-306, 1990